Optimizing the Societal Benefits of the Annual Influenza Vaccine: A Stochastic Programming Approach

被引:30
作者
Oezaltin, Osman Y. [1 ]
Prokopyev, Oleg A. [2 ]
Schaefer, Andrew J. [2 ]
Roberts, Mark S. [3 ]
机构
[1] Univ Waterloo, Dept Management Sci, Fac Engn, Waterloo, ON N2L 3G1, Canada
[2] Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Dept Hlth Policy & Management, Pittsburgh, PA 15261 USA
基金
美国国家科学基金会;
关键词
OPTIMIZATION;
D O I
10.1287/opre.1110.0988
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
Seasonal influenza is a major public health concern, and the first line of defense is the flu shot. Antigenic drifts and the high rate of influenza transmission require annual updates to the flu shot composition. The World Health Organization recommends which flu strains to include in the annual vaccine, based on surveillance and epidemiological analysis. There are two critical decisions regarding the flu shot design. One is its composition; currently, three strains constitute the flu shot, and they influence vaccine effectiveness. Another critical decision is the timing of the composition decisions, which affects the flu shot production. Both of these decisions have to be made under uncertainty many months before the flu season starts. We quantify the trade-offs involved through a multistage stochastic mixed-integer program that determines the optimal flu shot composition and its timing in a stochastic and dynamic environment. We incorporate risk sensitivity through mean-risk models. Our results provide valuable insights for pressing policy issues.
引用
收藏
页码:1131 / 1143
页数:13
相关论文
共 53 条
[1]   Convexity and decomposition of mean-risk stochastic programs [J].
Ahmed, S .
MATHEMATICAL PROGRAMMING, 2006, 106 (03) :433-446
[2]  
Ahmed S., 2004, Mean-risk objectives in stochastic programming
[3]   Shaping the phylogenetic tree of influenza by cross-immunity [J].
Andreasen, Viggo ;
Sasaki, Akira .
THEORETICAL POPULATION BIOLOGY, 2006, 70 (02) :164-173
[4]  
[Anonymous], 2010, MORBIDITY MORTALITY
[5]  
[Anonymous], VACC REL BIOL PROD A
[6]  
Belongia E., 2008, Morbidity and Mortality Weekly Report, V57, P393
[7]   Influenza vaccine: The challenge of antigenic drift [J].
Carrat, F. ;
Flahault, A. .
VACCINE, 2007, 25 (39-40) :6852-6862
[8]  
*CDC, 2001, MMWR-MORBID MORTAL W, V50, P582
[9]  
*CDC, 2010, FLU SYMPT SEV
[10]  
*CDC, 2010, WELL DOES SEAS FLU V